Literature DB >> 26191120

Head and neck rhabdomyosarcoma: follow-up results of four cases and review of the literature.

Dong-Ni Zhou1, Qing-Qing Yang2, Zhong-Lin Li3, Zhi-Yong Pan4, Yan-Fei Deng5.   

Abstract

Head and neck rhabdomyosarcoma (HNRMS) is exceedingly rare and poorly documented. The difficult diagnosis often causes a poor prognosis and high mortality. Hence, we report 4 cases of HNRMS and their follow-up outcomes, and review the clinicopathological features of this rare tumor. The 4 patients ranged in age from 5 to 29 years. Among them, 3 patients had a good prognosis after combination of radiotherapy and chemotherapy or surgery alone. Another patient survived for only 3 months after diagnosis without therapy. Deeply insight into HNRMS might improve the ability of diagnosis and treatment for this disease.

Entities:  

Keywords:  Rhabdomyosarcoma; follow-up; head and neck

Mesh:

Year:  2015        PMID: 26191120      PMCID: PMC4502992     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

Review 1.  Rhabdomyosarcoma.

Authors:  Arnold C Paulino; Mehmet Fatih Okcu
Journal:  Curr Probl Cancer       Date:  2008 Jan-Feb       Impact factor: 3.187

2.  Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group.

Authors:  W Lawrence; J R Anderson; E A Gehan; H Maurer
Journal:  Cancer       Date:  1997-09-15       Impact factor: 6.860

Review 3.  Update on rhabdomyosarcoma.

Authors:  Roshni Dasgupta; David A Rodeberg
Journal:  Semin Pediatr Surg       Date:  2012-02       Impact factor: 2.754

4.  Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005.

Authors:  Simona Ognjanovic; Amy M Linabery; Bridget Charbonneau; Julie A Ross
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

5.  Rhabdomyosarcoma of the head and neck in children.

Authors:  J Hicks; C Flaitz
Journal:  Oral Oncol       Date:  2002-07       Impact factor: 5.337

6.  Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.

Authors:  Odile Oberlin; Annie Rey; Elizabeth Lyden; Gianni Bisogno; Michael C G Stevens; William H Meyer; Modesto Carli; James R Anderson
Journal:  J Clin Oncol       Date:  2008-05-10       Impact factor: 44.544

7.  A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan.

Authors:  Hajime Hosoi; Satoshi Teramukai; Yoshifumi Matsumoto; Kunihiko Tsuchiya; Tomoko Iehara; Jun-ichi Hara; Tetsuo Mitsui; Michio Kaneko; Yoshiro Hatae; Yutaka Hayashi; Osamu Mabuchi; Naoto Adachi; Yasuhide Morikawa; Shin-ichiro Nishimura; Masaaki Kumagai; Hideo Takamatsu; Tadashi Sawada; Tohru Sugimoto
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402

8.  Epidemiological characteristics and survival studies of rhabdomyosarcoma in East egypt: a five-year multicenter study.

Authors:  M A Badr; Y A Al-Tonbary; A K Mansour; T H Hassan; M R Beshir; A Darwish; R A El-Ashry
Journal:  ISRN Oncol       Date:  2012-05-17

9.  Computed tomography and magnetic resonance imaging observations of rhabdomyosarcoma in the head and neck.

Authors:  Jingqi Zhu; Jianhua Zhang; Guangyu Tang; Shiyou Hu; Guoxing Zhou; Yongkang Liu; Lingling Dai; Zhongqiu Wang
Journal:  Oncol Lett       Date:  2014-04-25       Impact factor: 2.967

Review 10.  Rhabdomyosarcoma in adolescent and young adult patients: current perspectives.

Authors:  Daniela Egas-Bejar; Winston W Huh
Journal:  Adolesc Health Med Ther       Date:  2014-06-17
View more
  2 in total

1.  Head and Neck Rhabdomyosarcoma: Clinical and Pathologic Characterization of Seven Cases.

Authors:  Eleanor Chen; Robert Ricciotti; Neal Futran; Dolphine Oda
Journal:  Head Neck Pathol       Date:  2016-11-28

Review 2.  Surgical Interventions for Advanced Parameningeal Rhabdomyosarcoma of Children and Adolescents.

Authors:  Paul J Choi; Joe Iwanaga; R Shane Tubbs; Emre Yilmaz
Journal:  Cureus       Date:  2018-01-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.